Rocket Pharmaceuticals’ $175 Million Public Offering

Pietro Martinoia
Tagged:

K&L Gates advised Rocket, and Latham advised underwriters.Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common stock…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now